DG Capital Management (Massachusetts)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-6,391
Closed -$533K 65
2016
Q2
$533K Sell
6,391
-22,595
-78% -$2.01M 0.57% 55
2016
Q1
$2.66M Sell
28,986
-7,690
-21% -$693K 2.61% 10
2015
Q4
$3.71M Sell
36,676
-14,609
-28% -$1.52M 3.31% 7
2015
Q3
$5.04M Buy
51,285
+12,885
+34% +$1.43M 3.39% 4
2015
Q2
$4.5M Buy
38,400
+1,075
+3% +$117K 2.71% 5
2015
Q1
$3.66M Sell
37,325
-6,295
-14% -$639K 2.21% 13
2014
Q4
$4.11M Buy
43,620
+55
+0.1% +$5.69K 2.38% 9
2014
Q3
$4.64M Sell
43,565
-2,250
-5% -$220K 2.83% 4
2014
Q2
$3.8M Sell
45,815
-31,420
-41% -$2.45M 2.17% 10
2014
Q1
$5.47M Sell
77,235
-13,965
-15% -$1.1M 3.24% 5
2013
Q4
$6.85M Sell
91,200
-4,805
-5% -$335K 3.82% 2
2013
Q3
$6.04M Sell
96,005
-8,295
-8% -$496K 3.42% 2
2013
Q2
$5.35M Buy
+104,300
New +$5.44M 3.24% 2

Other funds holding GILD

DG Capital Management (Massachusetts)'s GILD Position: Q3 2016 in Review

DG Capital Management (Massachusetts) sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 6,391 shares — an estimated $533K sold.

DG Capital Management (Massachusetts) first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $6.85M in Q4 2013. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • DG Capital Management (Massachusetts) reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • DG Capital Management (Massachusetts) sold 6,391 Gilead Sciences shares in Q3 2016, an estimated $533K.
  • DG Capital Management (Massachusetts) first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
  • DG Capital Management (Massachusetts)'s Gilead Sciences position peaked at $6.85M in Q4 2013.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.